2017 - Volume 2 - Issue 1 Articles
-
Review Article | ArticleMarch 21, 2017 | Pages : 205 - 450Abstract Guanfacine extended release (GXR) is a a2A-adrenoreceptor agonist approved by the European Medicines Agency (EMA) in September 2015 for treatment of attention-deficit/hyperactivity disorder (ADHD) in child and young people (CYP) aged 6–17 year, whe.....
-
Research Article | ArticleBy Robert EmeMarch 21, 2017 | Pages : 205 - 450Abstract This review examined the findings from the six most recent longitudinal studies of ADHD with a goal of answering the question of what the future likely holds for an individual with childhood ADHD. When the findings from these studies were combined wi.....
-
Short Communication | ArticleBy Annemieke C. Vink Marye Hogenboom Monique CH van Bruggen-Rufi Raymund AC Roos Wilco P. AchterbergMay 09, 2017 | Pages : 205 - 450Abstract Background/Introduction: This article reports the process evaluation of a multi-center randomized controlled trial in which the effect of music therapy in Huntington’s Disease (HD) was studied. The beneficial affects of this complex intervention, r.....
-
Research Article | ArticleJune 29, 2017 | Pages : 205 - 450Abstract Context: Choking and accidental falls are common incidents in patients with Huntington’s disease (HD). It is not clear which emotional and cognitive factors contribute to the development of fear of choking (FoC) or fear of falling (FoF). Objectiv.....